Tuesday, February 07, 2017 10:20:02 AM
February 7, 2017 Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce that Dr. Ricardo Rivera Acevedo, a scientist within its research arm, Cannevert Therapeutics Ltd., has been invited to attend the Masterclass on Medicinal Cannabis in Leiden, The Netherlands from March 5-10, 2017.
Bedrocan, a multinational company that has been growing and supplying pharmaceutical grade medicinal cannabis since the early 1980s, hosts this 5-day seminar yearly. The selection process involves selecting from an international pool of applicants with diverse backgrounds and research interests from the industry. Bedocran’s Head of Research and Education, Dr. Arno Hazekamp, has brought together several world experts to review the historical significance, regulatory status, chemical composition, clinical research designs, quality control/assurance matters, and latest cultivation techniques related to medicinal cannabis.
Veritas CEO, Dr. Lui Franciosi stated that “We are very pleased to have one of the Cannevert scientists attend this event. It demonstrates Bedrocan’s interest in our scientific approach of using functional techniques to assess the potential of whole plant extracts for specific disease conditions. This event will maximize the exchange of best practices between professionals, including policy makers, who are actively involved in the medicinal cannabis industry.”
Recent VRT News
- Vertiv Announces Date of First Quarter 2024 Earnings Release and Conference Call • Business Wire • 04/10/2024 12:00:00 PM
- Vertiv Unveils End-to-End AI Power and Cooling Solutions to Simplify Data Center Infrastructure Selection and Deployment in North America • Business Wire • 04/04/2024 09:36:00 PM
- Vertiv Joins the NVIDIA Partner Network • Business Wire • 03/18/2024 10:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:55:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:33:12 PM
- Vertiv Declares Quarterly Dividend • Business Wire • 03/07/2024 09:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 02:01:32 AM
- Vertiv to Participate in Upcoming J.P. Morgan Industrials Conference • Business Wire • 03/04/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2024 12:45:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 11:02:03 AM
- Vertiv Reports Strong Fourth Quarter Results and Provides Full Year 2024 Outlook • Business Wire • 02/21/2024 10:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:03 PM
- Vertiv Announces Date of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • Business Wire • 01/31/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:31:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:28:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:27:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:27:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:27:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:27:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:26:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:26:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:26:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:26:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:25:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 02:28:02 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM